Sino Biopharmaceutical Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SBMFF research report →
About the company
Sino Biopharmaceutical Limited operates as a leading investment holding entity and a research and development-focused pharmaceutical conglomerate, primarily active within the People's Republic of China. Its business activities are organized into three primary divisions: Modernised Chinese Medicines and Chemical Medicines, Investment initiatives, and other miscellaneous operations. The company offers a comprehensive range of pharmaceutical products spanning various therapeutic areas.
- CEO
- S. Y. Tse
- IPO
- 2010
- Employees
- 24,379
- HQ
- Wan Chai, HK
Price Chart
- Market Cap
- $10.57B
- P/E
- 31.46
- P/S
- 2.29
- P/B
- 2.40
- EV/EBITDA
- 11.26
- Div Yield
- 2.11%
- Gross Margin
- 82.07%
- Op Margin
- 21.84%
- Net Margin
- 7.36%
- ROE
- 7.22%
- ROIC
- 8.99%
- Revenue
- $31.01B · 7.44%
- Net Income
- $2.28B · -34.77%
- EPS
- $0.13 · -35.00%
- Op Income
- $6.64B
- FCF YoY
- 34.20%
- 52W High
- $1.24
- 52W Low
- $0.37
- 50D MA
- $0.87
- 200D MA
- $0.83
- Beta
- 0.60
- Avg Volume
- 104
Get TickerSpark's AI analysis on SBMFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SBMFF coverage
Recent articles, reports, and earnings notes.
No research on SBMFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SBMFF report →Similar companies
Peers in the same neighborhood.